Knight Cancer clinicians at Tuality/OHSU Cancer Center are the first in Oregon to offer a treatment option that will improve outcomes for patients with bladder cancer who cannot tolerate surgery or...
Researchers have uncovered a potential drug target for stopping castration-resistant prostate tumors – the second leading cause of cancer death in the U.S. For decades, drug development for...
Serving Oregonians. Delivering discoveries. Developing talented clinicians and scientists. Leading the way. Here's a look at the accomplishments of the people at the Knight Cancer Institute. They...
(OHSU/Joe Rojas-Burke) Ironworkers placed the final steel beam onto the Knight Cancer Research Building on Monday. And in the "topping out" tradition, members of Ironworkers Local 29 signed the...
Finding new treatment targets for aggressive prostate cancer, lymphoma and leukemia. Visualizing how breast tumors grow resistant to drug therapy. Using mobile phone sensors to track symptoms...
Knight Cancer Institute researchers Brian Druker, M.D., and Michael Heinrich, M.D., are among the "world's most influential scientific minds," according to the annual list produced by Thomson...